• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长非编码 RNA HIKER 通过 CSNK2B 调节 Monge 病中的红细胞生成。

Long noncoding RNA HIKER regulates erythropoiesis in Monge's disease via CSNK2B.

机构信息

Division of Respiratory Medicine, Department of Pediatrics, and.

Department of Cell and Developmental Biology, UCSD, La Jolla, California, USA.

出版信息

J Clin Invest. 2023 Jun 1;133(11):e165831. doi: 10.1172/JCI165831.

DOI:10.1172/JCI165831
PMID:37022795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10231995/
Abstract

Excessive erythrocytosis (EE) is a major hallmark of patients suffering from chronic mountain sickness (CMS, also known as Monge's disease) and is responsible for major morbidity and even mortality in early adulthood. We took advantage of unique populations, one living at high altitude (Peru) showing EE, with another population, at the same altitude and region, showing no evidence of EE (non-CMS). Through RNA-Seq, we identified and validated the function of a group of long noncoding RNAs (lncRNAs) that regulate erythropoiesis in Monge's disease, but not in the non-CMS population. Among these lncRNAs is hypoxia induced kinase-mediated erythropoietic regulator (HIKER)/LINC02228, which we showed plays a critical role in erythropoiesis in CMS cells. Under hypoxia, HIKER modulated CSNK2B (the regulatory subunit of casein kinase 2). A downregulation of HIKER downregulated CSNK2B, remarkably reducing erythropoiesis; furthermore, an upregulation of CSNK2B on the background of HIKER downregulation rescued erythropoiesis defects. Pharmacologic inhibition of CSNK2B drastically reduced erythroid colonies, and knockdown of CSNK2B in zebrafish led to a defect in hemoglobinization. We conclude that HIKER regulates erythropoiesis in Monge's disease and acts through at least one specific target, CSNK2B, a casein kinase.

摘要

红细胞增多症(EE)是患有慢性高山病(CMS,也称为 Monge 病)患者的主要特征,是导致成年早期发病率和死亡率升高的主要原因。我们利用独特的人群,一个生活在高海拔地区(秘鲁)表现出 EE,而另一个在同一海拔和地区的人群,没有 EE 的证据(非 CMS)。通过 RNA-Seq,我们确定并验证了一组长链非编码 RNA(lncRNAs)的功能,这些 lncRNAs 调节 Monge 病中的红细胞生成,但在非 CMS 人群中则没有。在这些 lncRNAs 中,缺氧诱导激酶介导的红细胞生成调节剂(HIKER)/LINC02228,我们发现它在 CMS 细胞的红细胞生成中起着关键作用。在缺氧条件下,HIKER 调节 CSNK2B(酪蛋白激酶 2 的调节亚基)。HIKER 的下调显著降低了 CSNK2B 的表达,从而显著减少了红细胞生成;此外,在 HIKER 下调的背景下上调 CSNK2B 可挽救红细胞生成缺陷。CSNK2B 的药理学抑制可显著减少红细胞集落,而 CSNK2B 在斑马鱼中的敲低导致血红蛋白化缺陷。我们得出结论,HIKER 调节 Monge 病中的红细胞生成,至少通过一个特定的靶标 CSNK2B(一种酪蛋白激酶)起作用。

相似文献

1
Long noncoding RNA HIKER regulates erythropoiesis in Monge's disease via CSNK2B.长非编码 RNA HIKER 通过 CSNK2B 调节 Monge 病中的红细胞生成。
J Clin Invest. 2023 Jun 1;133(11):e165831. doi: 10.1172/JCI165831.
2
ARID1B, a molecular suppressor of erythropoiesis, is essential for the prevention of Monge's disease.ARID1B 是一种红细胞生成的分子抑制剂,对于预防 Monge 病是必需的。
Exp Mol Med. 2022 Jun;54(6):777-787. doi: 10.1038/s12276-022-00769-1. Epub 2022 Jun 7.
3
Protective role of estrogen against excessive erythrocytosis in Monge's disease.雌激素对 Monge 病中红细胞增多症的保护作用。
Exp Mol Med. 2021 Jan;53(1):125-135. doi: 10.1038/s12276-020-00550-2. Epub 2021 Jan 20.
4
Senp1 drives hypoxia-induced polycythemia via GATA1 and Bcl-xL in subjects with Monge's disease.在患有蒙氏病的受试者中,Senp1通过GATA1和Bcl-xL驱动缺氧诱导的红细胞增多症。
J Exp Med. 2016 Nov 14;213(12):2729-2744. doi: 10.1084/jem.20151920. Epub 2016 Nov 7.
5
New Insights into the Genetic Basis of Monge's Disease and Adaptation to High-Altitude.高海拔适应与 Monge 病遗传基础的新见解
Mol Biol Evol. 2017 Dec 1;34(12):3154-3168. doi: 10.1093/molbev/msx239.
6
New genetic and physiological factors for excessive erythrocytosis and Chronic Mountain Sickness.红细胞增多症和慢性高山病的新遗传及生理因素。
J Appl Physiol (1985). 2015 Dec 15;119(12):1481-6. doi: 10.1152/japplphysiol.00271.2015. Epub 2015 Aug 13.
7
[Expression of GATA-1 and GATA-2 in the bone marrow of patients with Monge's disease].[蒙氏病患者骨髓中GATA-1和GATA-2的表达]
Zhonghua Xue Ye Xue Za Zhi. 2007 Aug;28(8):537-40.
8
Increased hypoxic proliferative response and gene expression in erythroid progenitor cells of Andean highlanders with chronic mountain sickness.慢性高原病安第斯高地人群红系祖细胞缺氧增殖反应和基因表达增加。
Am J Physiol Regul Integr Comp Physiol. 2020 Jan 1;318(1):R49-R56. doi: 10.1152/ajpregu.00250.2019. Epub 2019 Oct 16.
9
Decreased plasma soluble erythropoietin receptor in high-altitude excessive erythrocytosis and Chronic Mountain Sickness.高海拔地区红细胞增多症和慢性高山病患者血浆可溶性促红细胞生成素受体降低。
J Appl Physiol (1985). 2014 Dec 1;117(11):1356-62. doi: 10.1152/japplphysiol.00619.2014. Epub 2014 Oct 16.
10
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.乙酰唑胺治疗蒙氏病:6个月治疗的疗效和耐受性
Am J Respir Crit Care Med. 2008 Jun 15;177(12):1370-6. doi: 10.1164/rccm.200802-196OC. Epub 2008 Apr 3.

引用本文的文献

1
DNA methylation in adaptation to high-altitude environments and pathogenesis of related diseases.DNA甲基化在适应高海拔环境及相关疾病发病机制中的作用
Hum Genomics. 2025 Aug 30;19(1):100. doi: 10.1186/s40246-025-00794-x.
2
Life destiny of erythrocyte in high altitude erythrocytosis: mechanisms underlying the progression from physiological (moderate) to pathological (excessive) high-altitude erythrocytosis.高原红细胞增多症中红细胞的生命历程:从生理性(适度)到病理性(过度)高原红细胞增多症进展的潜在机制。
Front Genet. 2025 Apr 2;16:1528935. doi: 10.3389/fgene.2025.1528935. eCollection 2025.
3
[Progress in multiomics research on high altitude polycythemia].

本文引用的文献

1
A pleiotropic hypoxia-sensitive enhancer is disrupted by adaptive alleles in Tibetans.一个多效性的低氧敏感增强子被藏族人群中的适应性等位基因破坏。
Sci Adv. 2022 Nov 25;8(47):eade1942. doi: 10.1126/sciadv.ade1942. Epub 2022 Nov 23.
2
Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α.通过抑制酪蛋白激酶 2(Casein Kinase 2,CK2)对 HuCCT-1 人胆管癌细胞的生长、血管生成和促凋亡作用,以及对胱冬肽酶-9/3(Caspase-9/3)、死亡受体-4(DR-4)、信号转导和转录激活因子-3/5(STAT-3/STAT-5)、凋亡蛋白抑制因子-1(Mcl-1)、真核翻译起始因子-2α(eIF-2α)和缺氧诱导因子-1α(HIF-1α)的调控。
Int J Mol Sci. 2022 Jun 6;23(11):6353. doi: 10.3390/ijms23116353.
3
[高原红细胞增多症的多组学研究进展]
Zhonghua Xue Ye Xue Za Zhi. 2024 Aug 14;45(8):795-800. doi: 10.3760/cma.j.cn121090-20240318-00100.
4
High altitude polycythemia and its maladaptive mechanisms: an updated review.高原红细胞增多症及其适应不良机制:最新综述
Front Med (Lausanne). 2024 Aug 27;11:1448654. doi: 10.3389/fmed.2024.1448654. eCollection 2024.
5
Altitude illnesses.高山病。
Nat Rev Dis Primers. 2024 Jun 20;10(1):43. doi: 10.1038/s41572-024-00526-w.
6
RACK1 Promotes Meningioma Progression by Activation of NF-κB Pathway via Preventing CSNK2B from Ubiquitination Degradation.RACK1通过阻止CSNK2B泛素化降解激活NF-κB通路促进脑膜瘤进展。
Cancers (Basel). 2024 Feb 13;16(4):767. doi: 10.3390/cancers16040767.
7
Phosphate sensing via PTC glycolysis.通过磷酸烯醇丙酮酸羧激酶糖酵解进行磷酸盐传感
Nat Rev Nephrol. 2023 May;19(5):277. doi: 10.1038/s41581-023-00710-3.
ARID1B, a molecular suppressor of erythropoiesis, is essential for the prevention of Monge's disease.ARID1B 是一种红细胞生成的分子抑制剂,对于预防 Monge 病是必需的。
Exp Mol Med. 2022 Jun;54(6):777-787. doi: 10.1038/s12276-022-00769-1. Epub 2022 Jun 7.
4
Protein kinase CK2: a potential therapeutic target for diverse human diseases.蛋白激酶 CK2:一种针对多种人类疾病的潜在治疗靶点。
Signal Transduct Target Ther. 2021 May 17;6(1):183. doi: 10.1038/s41392-021-00567-7.
5
Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach.比较Ck2抑制剂的疗效和选择性:一种磷酸化蛋白质组学方法
Eur J Med Chem. 2021 Mar 15;214:113217. doi: 10.1016/j.ejmech.2021.113217. Epub 2021 Jan 27.
6
Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer.蛋白激酶2(CK2):癌症中免疫细胞发育和功能的潜在调节因子。
Immunol Med. 2021 Sep;44(3):159-174. doi: 10.1080/25785826.2020.1843267. Epub 2020 Nov 9.
7
Tips for Successful lncRNA Knockdown Using Gapmers.利用 Gapmers 成功进行 lncRNA 敲低的技巧。
Methods Mol Biol. 2020;2176:121-140. doi: 10.1007/978-1-0716-0771-8_9.
8
Expanded encyclopaedias of DNA elements in the human and mouse genomes.人类和小鼠基因组中 DNA 元件的扩展百科全书。
Nature. 2020 Jul;583(7818):699-710. doi: 10.1038/s41586-020-2493-4. Epub 2020 Jul 29.
9
Regulation of TMEM16A by CK2 and Its Role in Cellular Proliferation.TMEM16A 的 CK2 调节及其在细胞增殖中的作用。
Cells. 2020 May 5;9(5):1138. doi: 10.3390/cells9051138.
10
Increased hypoxic proliferative response and gene expression in erythroid progenitor cells of Andean highlanders with chronic mountain sickness.慢性高原病安第斯高地人群红系祖细胞缺氧增殖反应和基因表达增加。
Am J Physiol Regul Integr Comp Physiol. 2020 Jan 1;318(1):R49-R56. doi: 10.1152/ajpregu.00250.2019. Epub 2019 Oct 16.